Bankinter | Cellnex (CLNX) has reached an agreement to sell 100% of its business in Austria, its subsidiary On Tower Austria, for €803 million. Part of the payment (€272 million) will be deferred in December 2028.
Opinion of the Bankinter analysis team;
Good news for Cellnex. This divestment is part of the process of selling non-strategic assets and will allow Cellnex to continue reducing debt, with the objective of reaching a DFN/EBITDA ratio of 5/6x in 2025/2026. Moreover, the sale price implies an EV/EBITDA of 20x versus 13x Cellnex’s share price.
We maintain our Buy recommendation.